Acute Cardiovascular Responses and Chronic Adaptations of Strength Exercise in Intermittent Claudication Patients
- Conditions
- Intermittent ClaudicationPeripheral Artery Disease
- Interventions
- Behavioral: ControlBehavioral: Resistance training
- Registration Number
- NCT02778568
- Lead Sponsor
- University of Pernambuco
- Brief Summary
The aim of this study was to analyze the effects of resistance exercise and training on cardiovascular function of peripheral artery disease patients.
- Detailed Description
Several studies have shown that strength training can promote important benefits for the cardiovascular system in healthy subjects and patients with chronic diseases. However, the effects of resistance exercise on cardiovascular function in intermittent claudication patients are unclear. In addition, it also do not know the chronic effects on cardiovascular function in these patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Had a graded treadmill test that was limited by claudication (2 minutes)
- Had an ankle brachial index <0.90
- Had systolic blood pressure ,160 mmHg and/or diastolic blood pressure,105 mmHg
- Were not performing any regular exercise program
- Were not using antihypertensive medications affecting the heart rate (e.g., b-blockers and nondihydropyridine calcium channel blockers)
- Were nonobese
- Individuals who have not undergone bypass surgery or angioplasty least one year ago
- Had no symptoms related to myocardial ischemia during the treadmill test
- Amputation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Control Patients who performed flexibility exercise Resistance Training Resistance training Patients performed resistance exercises
- Primary Outcome Measures
Name Time Method Change in blood pressure Change from baseline to 12 and 24 weeks
- Secondary Outcome Measures
Name Time Method Change in Health related Quality of life Change from baseline to 12 and 24 weeksBaseline, 12 wks and 24 wks Change Serum Cholesterol Change from baseline to 12 and 24 weeks Change in body fat Change from baseline to 12 and 24 weeks Change in serum glucose Change from baseline to 12 and 24 weeks Change in Walking distance Change from baseline to 12 and 24 weeks Change in Muscle blood flow of limbs Change from baseline to 12 and 24 weeks Muscle blood flow assessed with venous occlusion plethysmography
Change in TNFalpha Change from baseline to 12 and 24 weeks Change in Score Short-physical performance battery Change from baseline to 12 and 24 weeks
Trial Locations
- Locations (1)
Emergency Hospital of Pernambuco - PROCAPE
🇧🇷Recife, PE, Brazil